CLINICAL TRIALS PROFILE FOR LURASIDONE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for lurasidone hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00044005 ↗ | Safety and Tolerability Study of Drug to Treat Schizophrenia | Completed | Sunovion | Phase 2 | 2002-09-01 | The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia. |
| NCT00088621 ↗ | A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia | Completed | Sunovion | Phase 2 | 2004-07-01 | A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia |
| NCT00088634 ↗ | A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia | Completed | Sunovion | Phase 2 | 2004-05-01 | A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia |
| NCT00549666 ↗ | A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects | Completed | Sunovion | Phase 1 | 2007-08-01 | A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen |
| NCT00549718 ↗ | Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia | Completed | Sunovion | Phase 3 | 2007-10-01 | Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo. |
| NCT00615433 ↗ | Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia | Completed | Sunovion | Phase 3 | 2008-01-01 | Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo. |
| NCT00641745 ↗ | Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia | Completed | Sunovion | Phase 3 | 2008-03-01 | Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long term among clinically stable patients. The study will also assess the long term effectiveness of lurasidone as compared to an active comparator. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for lurasidone hydrochloride
Condition Name
Clinical Trial Locations for lurasidone hydrochloride
Trials by Country
Clinical Trial Progress for lurasidone hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for lurasidone hydrochloride
Sponsor Name
